Vaccines for Alzheimer’s: exploiting similarities with Down syndrome
One approach to overcome continuing challenges facing drug research and development for Alzheimer’s is a...
Read More...
Focus:
-
![Trintellix depression Japan]()
Takeda and Lundbeck’s Trintellix approved in Japan for depression
Takeda has announced that its drug Trintellix (vortioxetine) has been approved by the Japanese Ministry...
Read More...
-
![using viruses to fight disease]()
Timeline: using viruses to fight disease
Since the invention of vaccines to treat infections in the 18th century, there have been...
Read More...
-
![]()
Novartis presents additional Zolgensma data in children with SMA
Novartis subsidiary AveXis has announced interim data for Zolgensma (onasemnogene abeparvovec-xioi) in children with spinal...
Read More...
-
![]()
Pfizer’s Upjohn and Mylan merger set to create drug and manufacturing juggernaut
This partnership will combine pipeline and marketed product portfolios, filling therapy area gaps as well...
Read More...
-
![]()
Andhra Pradesh and Telangana: Indian contract manufacturing powerhouses for US API supply
In line with the global perception of a strong generics manufacturing industry in India, the...
Read More...
-
![AstraZeneca revises Linzess deal with Ironwood Pharmaceuticals]()
AstraZeneca revises Linzess deal with Ironwood Pharmaceuticals
AstraZeneca has revised its agreement with Ironwood Pharmaceuticals for irritable bowel syndrome with constipation (IBS-C)...
Read More...
-
![challenges NHS cancer treatment]()
Westminster Health Forum: challenges facing NHS cancer treatment
At the Westminster Health Forum’s recent cancer care in England conferences, speakers from across the...
Read More...
-
![Keytruda combination endometrial carcinoma]()
FDA approves Keytruda plus Lenvima for endometrial carcinoma
The US Food and Drug Administration (FDA) has approved Merck’s anti-programmed cell death protein 1...
Read More...
-
![Ebola vaccine Merck]()
FDA grants Merck’s V920 Ebola vaccine priority review
Merck has announced that the US Food and Drug Administration (FDA) has accepted a biologics...
Read More...
